LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Leadership Changes Ovid Therapeutics recently promoted Meg Alexander to the position of President and Chief Operating Officer, showcasing a focus on strengthening leadership. This change presents an opportunity for sales professionals to engage with new decision-makers and potentially align products or services with the company's evolving strategy under new leadership.

Strategic Hiring of Chief Development Officer The appointment of Amanda Banks, M.D., as the Chief Development Officer at Ovid Therapeutics signals a strategic move towards advancing developmental initiatives. Sales development representatives can leverage this by exploring potential collaborations or offering solutions that align with the company's development goals, creating new sales opportunities.

Partnership Expansion with Marinus Pharmaceuticals Ovid Therapeutics partnering with Marinus Pharmaceuticals indicates a focus on expanding capabilities and potentially diversifying their offerings. This partnership presents an opening for business development professionals to explore synergies, pitch complementary products or services, and establish strategic collaborations, ultimately leading to new sales prospects.

Market Cap Increase and Insider Stock Buying With Ovid Therapeutics reaching a market cap of $197 million and benefiting from insider stock buying, there is a demonstration of confidence in the company's future prospects. Sales professionals can leverage this positive financial indicator to position their offerings as valuable investments for Ovid, capitalizing on the company's growth trajectory to drive potential sales opportunities.

Investment by FFT Wealth Management LLC The investment of $1.27 million by FFT Wealth Management LLC into Ovid Therapeutics showcases external interest and confidence in the company's potential. This demonstrates a potential avenue for sales development representatives to engage with investors and present how their products or services can contribute to Ovid's growth, creating pathways for new business opportunities.

Similar companies to Ovid Therapeutics

Ovid Therapeutics Tech Stack

Ovid Therapeutics uses 8 technology products and services including Google Analytics, Akamai, Shopify, and more. Explore Ovid Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Akamai
    Content Delivery Network
  • Shopify
    E-commerce
  • Font Awesome
    Font Scripts
  • Google Font API
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • reCAPTCHA
    Security
  • X-XSS-Protection
    Security

Media & News

Ovid Therapeutics's Email Address Formats

Ovid Therapeutics uses at least 1 format(s):
Ovid Therapeutics Email FormatsExamplePercentage
FLast@ovidrx.comJDoe@ovidrx.com
71%
Last@ovidrx.comDoe@ovidrx.com
24%
First.Last@ovidrx.comJohn.Doe@ovidrx.com
4%
FL@ovidrx.comJD@ovidrx.com
1%

Frequently Asked Questions

Where is Ovid Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Ovid Therapeutics's main headquarters is located at 441 9th Avenue New York, New York 10001 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Ovid Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Ovid Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ovid Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Ovid Therapeutics is a publicly traded company; the company's stock symbol is OVID.

What is Ovid Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Ovid Therapeutics's official website is ovidrx.com and has social profiles on LinkedIn.

How much revenue does Ovid Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, Ovid Therapeutics's annual revenue reached $7.5M.

What is Ovid Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Ovid Therapeutics's SIC code is 8049 - Offices and Clinics of Health Practitioners, Not Elsewhere Classified NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ovid Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, Ovid Therapeutics has approximately 47 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Business & Financial Officer: J. R.Chief Scientific Officer: Z. Z.Chief Operating Officer: J. T.. Explore Ovid Therapeutics's employee directory with LeadIQ.

What industry does Ovid Therapeutics belong to?

Minus sign iconPlus sign icon
Ovid Therapeutics operates in the Biotechnology Research industry.

What technology does Ovid Therapeutics use?

Minus sign iconPlus sign icon
Ovid Therapeutics's tech stack includes Google AnalyticsAkamaiShopifyFont AwesomeGoogle Font APIyepnope.jsreCAPTCHAX-XSS-Protection.

What is Ovid Therapeutics's email format?

Minus sign iconPlus sign icon
Ovid Therapeutics's email format typically follows the pattern of . Find more Ovid Therapeutics email formats with LeadIQ.

When was Ovid Therapeutics founded?

Minus sign iconPlus sign icon
Ovid Therapeutics was founded in 2014.
Ovid Therapeutics

Ovid Therapeutics

Biotechnology ResearchNew York, United States11-50 Employees

Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions.  For those who need relief, we must succeed—their hopes are our aspirations. We act with urgency, ingenuity and integrity as we seek a future free of seizures. 

At Ovid, we are pursuing small molecule compounds with untapped potential. Applying our nimble, proven approach to accelerate clinical development, we aim to translate our molecules into first-in-class or best-in-class medicines. The patient, clinician and academic communities are our collaborators in every step of development from bench to bedside.  

Our accomplished team holds a track record of success in making medicines for rare diseases and neurology. Our goal is bold for the communities we serve. 

For more information, please visit www.ovidrx.com.  

Review our community guidelines: http://www.ovidrx.com/community-guidelines/ 

Section iconCompany Overview

Headquarters
441 9th Avenue New York, New York 10001 US
Phone number
Website
ovidrx.com
SIC Code
8049 - Offices and Clinics of Health Practitioners, Not Elsewhere Classified
Stock Symbol
OVID
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $10M

    Ovid Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    Ovid Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.